Neuropsychopharmacology
- Psychedelics produce enduring enhancement of reward responsiveness in male rats2 months ago
- The neuroanatomy of depression: weak but replicable effects in 4021 individuals from three clinical cohorts2 months ago
- Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study2 months ago
- Correction: Cue labeling reduces cigarette craving and associated neural activity2 months ago
- In memoriam – Ming T. Tsuang, M.D., Ph.D., D.Sc2 months ago
- Long-term effects of adolescent risperidone treatment on the mouse cortex2 months ago
- Pharmacokinetics and concentration-behavioral effect relationships differ between brain subcompartments2 months ago
Journal of Psychopharmacology
- Oxytocin prevents ketamine-induced executive control deficits in macaque monkeys4 months ago
- Cardiovascular mortality and depression: A systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity4 months ago
- Effects of benzodiazepines on saccadic eye movements: A systematic review and meta-analysis4 months ago
- 5-HT1A receptor blockade potentiates the subjective effects of DMT4 months ago
- Effects of psychedelic use on authoritarian attitudes revisited4 months ago
- Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depression5 months ago
- The effects of the PDE4 inhibitor roflumilast on cognitive performance after a cerebrovascular accident: a double-blind randomized placebo-controlled trial with an open label extension (ROSTMEMA)5 months ago
European Neuropsychopharmacology
- Evidence of phenotypes indexing cognitive resilience and vulnerability in the early course of mood and psychosis spectrum illness; mapping the latent structure, characteristics, and longitudinal stability of cognitive heterogeneity6 months ago
- Is the time ripe for psychiatry to adopt a “mental health engineering” lens?6 months ago
- Involuntary movements integral to psychotic illness: a ‘circular epistemological journey’ informing the pathobiology and treatment of psychosis and reconceptualising tardive dyskinesia6 months ago
- Critical considerations on the trial of FAAH inhibitor JNJ-42165279 in major depressive disorder with anxious distress7 months ago
- Unraveling the genetic architecture of depression-atherosclerosis comorbidity: a paradigm shift in understanding mind-heart connections7 months ago
- Methodological points for consideration: Enhancing the interpretation of the COH-FIT findings7 months ago
- Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study7 months ago